Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

SARS-CoV-2
© Martin Schauflinger

Clinical trials for SARS-CoV-2 vaccine set to start September

Joint vaccine development under the roof of the DZIF: Vaccine is currently being manufactured for use in clinical trials

A potential vaccine against SARS-CoV-2 is to undergo first clinical trials on

HIV
© NIAID

Critical window for re-infection with HIV after stem cell transplantation

So far, allogeneic stem cell transplantation for the treatment of severe blood cancers has been the only medical intervention to have cured at least three people infected with the HI virus (HIV). It

Infectious Disease Specialist Christian Keller receives the 2020 Memento Research Award

Dr Christian Keller, from Philipps-University Marburg and the German Center for Infection Research, and Dr Anke Osterloh, Research Center Borstel, were awarded this year’s "Memento Award for neglected

Coronaviren
© Tumisu auf Pixabay

Development of a new antiviral agent against SARS-CoV-2

The search for effective drugs against the new coronavirus is currently a top priority at the German Center for Infection Research (DZIF). Developing inhibitors of viral replication is a promising

Löwenkids help scientists
© Alexander Dummer

“LoewenKIDS” help scientists in a COVID-19 study

Currently, little is known about children and their susceptibility to the new coronavirus. It has been observed that young children have rarely presented with COVID-19 up to now. No specific

Stenotrophomonas maltophilia
© E. Abda & I. Alio/ Mikrobiologie, Universität Hamburg

Global spread of the multi-resistant pathogen Stenotrophomonas maltophilia

An international consortium found a remarkable global spread of strains of a multi-resistant bacterium that can cause severe infections – Stenotrophomonas maltophilia. The study, published under the

ReFRAME
© Scripps Research/ReFRAME

Search for COVID-19 drugs: Researchers rely on known substances

MHH professor and DZIF scientist Thomas Pietschmann leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in

MERS coronavirus particles
© NIAID

Promising MERS coronavirus vaccine trial on humans—useful insights for vaccine development against SARS-CoV-2

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths. These include the SARS coronavirus outbreak in 2002

Coronavirus
© Fusion Medical Animation

SARS-CoV-2: Isolation of neutralising antibodies

Alongside developing vaccines, scientists at the German Center for Infection Research (DZIF) are working at high speed to develop new drugs to improve the treatment of COVID-19 patients. A DZIF

Klinische Studien site
© CoWomen on Unsplash

The DZIF and University Hospital Cologne compile overview of SARS-CoV-2 and COVID-19 trials in Germany

In the global fight against the new coronavirus, an increasing number of clinical trials are being conducted on drugs to fight the virus in many countries of the world including Germany. In order to